Low-dose vaginal estrogen for dryness and atrophy - [Medication] - Quest Diagnostics Patient Health Library Topic Contents - Examples - How It Works - Why It Is Used - How Well It Works - Side Effects - What To Think About - References Low-dose vaginal estrogen for dryness and atrophy - [Medication] - Quest Diagnostics Patient Health Library Low-dose vaginal estrogen for dryness and atrophy - [Medication] - Quest Diagnostics Patient Health Library Hormones, Sexual and reproductive organs,...
Estrogen therapy for dysfunctional uterine bleeding - [Medication] - Quest Diagnostics Patient Health Library Topic Contents - Examples - How It Works - Why It Is Used - How Well It Works - Side Effects - What To Think About - References Estrogen therapy for dysfunctional uterine bleeding - [Medication] - Quest Diagnostics Patient Health Library Estrogen therapy for dysfunctional uterine bleeding - [Medication] - Quest Diagnostics Patient Health Library Conjugated Estrogen, Conjugated...
Estrogen replacement therapy (ERT) - [Medication] - Quest Diagnostics Patient Health Library Topic Contents - Examples - How It Works - Why It Is Used - How Well It Works - Side Effects - What To Think About - References Estrogen replacement therapy (ERT) - [Medication] - Quest Diagnostics Patient Health Library Estrogen replacement therapy (ERT) - [Medication] - Quest Diagnostics Patient Health Library Hormones, Sexual and reproductive organs, Sexual health, Women’s...
http://www.fda.gov/cder/orange/appendix_a.txt IRRIGANT, NEOMYCIN SULFATE NEOSPORIN, BACITRACIN ZINC NEOSPORIN, GRAMICIDIN NEOSPORIN, NEOMYCIN SULFATE (OTC) NEOTHYLLINE, DYPHYLLINE NEOTRIZINE, TRISULFAPYRIMIDINES (SULFADIAZINE;SULFAMERAZINE; SULFAMETHAZINE) NEPHRAMINE 5.4%, AMINO ACIDS NEPHROFLOW, IODOHIPPURATE SODIUM, I-123 NEPTAZANE, METHAZOLAMIDE NESACAINE, CHLOROPROCAINE HYDROCHLORIDE NESACAINE-MPF, CHLOROPROCAINE...
http://www.fda.gov/cder/foi/appletter/1999/40296LTR.PDF ANDA 40- 296 November 1, 1999 Duramed Pharmaceuticals, IncEstropipate Tablets USP, 0.75 mg, 1.5 mg and 3 mg
http://www.fda.gov/cder/foi/appletter/1999/40296LTR.PDF page 1
THE MERCK MANUAL OF GERIATRICS, Index E parkinsonism 436 Estazolam 456 Estradiol for estrogen replacement therapy 1212-1215 silastic rings with 1214 transdermal 1214 Estrogen 1212-1215 (see also Estrogen replacement therapy ) age-related change in 1384t in Alzheimer's disease 367 in angiodysplasia 1052 breast cancer and 716 deficiency of 656t in prostate cancer 1 186 receptors for, in breast cancer treatment 1225 sexual...
THE MERCK MANUAL OF GERIATRICS, Index E parkinsonism 436 Estazolam 456 Estradiol for estrogen replacement therapy 1212-1215 silastic rings with 1214 transdermal 1214 Estrogen 1212-1215 (see also Estrogen replacement therapy ) age-related change in 1384t in Alzheimer's disease 367 in angiodysplasia 1052 breast cancer and 716 deficiency of 656t in prostate cancer 1186 receptors for, in breast cancer treatment 1225 sexual...
Maximum Recommended Therapeutic Dose (MRTD) Database Maximum Recommended Therapeutic Dose (MRTD) Database (1,235 pharmaceuticals) A -- B- - C -- D -- E -- F-G -- H-K -- L -- M -- N -- O -- P -- Q-R -- S -- T -- U-Z MRTD--- (mg/kg--- bw/day) -- Generic Chemical Name Chemical Structure (SMILES Code) 3.00000-- Acemetacin C1=C(OC)C=C3C(=C1)N(C(=O)C2=CC=C(Cl)C=C2)C(C)=C3CC(=O)OCC(O)=O 0.20000-- Acenocoumarol C1=CC=C3C(=C1)OC(=O)C(C(CC(C)=O...
OGD Suitability Tracking Reports (Sorted by Petition Number) as of 1/5/2004 - TABLET; ORAL Approved 2/28/2003- BACLOFEN 10 mg, 20 mg - 02P-0078/CP1 KLEINFELD, KAPLAN & BECKER - ORALLY DISINTEGRATING TABLETS Approved 2/5/2003- OXYCODONE 5mg, 7.5mg, 10mg ACETAMINOPHEN 300mg - 02P-0105/CP1 LACHMAN CONSULTANT SERVICES - TABLETS Approved 8/6/2002- CARISOPRODOL 350 mg - 02P-0138/CP1 LACHMAN CONSULTANT SERVICES - ORALLY DISINTEGRATING TABLETS Withdrawn 7/25/2002- ...
OGD Suitability Tracking Reports (Sorted by Drug Name) as of 1/5/2004 FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER - Search - -OGD Suitability Tracking Report (Sorted by Drug Name) as of 1/5/2004 Drug/Strength Petition No/Firm Dosage Form Status Status Date ACETAMINOPHEN 200MG;200MG; 200MG HYDROCODONE BITARTRATE 5MG;7.5MG;10MG - 02P-0004/CP1 SHOTWELL AND CARR, INCESTROPIPATE ...
1997 Abbreviated New Drug Applications (Generic Drugs) Generic Drug Approval Packages These drug approval packages, sorted by product trade name, are supplied by the CDER Freedom of Electronic Information Office
Comprehensive List of Current Guidance Documents at the Food and Drug Administration page 28
author: FDA
Prescription and OTC Drug Product List 11/1999 Prescription and Over-the-Counter Drug Product List - 19th Edition Cumulative Supplement Number 11: November 1999 [ Prescription - OTC ] - ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ALBUTEROL SULFATE BUPROPION HYDROCHLORIDE SOLUTION; INHALATION TABLET; ORAL ALBUTEROL SULFATE - ADD - BUPROPION HCL - ADD - AN MORTON GROVE EQ 0.083% BASE N75394 001 - ADD - AB TEVA 100MG...
Prescription and OTC Drug Product List 8/1999 Prescription and Over-the-Counter Drug Product List - 19th Edition Cumulative Supplement Number 8: August 1999 [ Prescription - OTC ] ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; BUTALBITAL; CAFFEINE AZATHIOPRINE SODIUM CAPSULE; ORAL INJECTABLE; INJECTION FEMCET IMURAN - DLT - AB MALLINCKRODT 325MG;50MG;40MG N89102 001 - ADD - AP + FARO PHARMS EQ 100MG BASE...
Prescription and OTC Drug Product List 1/2001 Prescription and Over-the-Counter Drug Product List - 21st Edition Cumulative Supplement Number 1: January 2001 [ Prescription - OTC ] ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE TABLET; ORAL TABLET; ORAL - ADD - ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE BISOPROLOL...
http://www.fda.gov/cber/gdlns/guidelst.txt Drug Advertising and Promotional Labeling DDMAC 2 Dissemination of Reprints of Certain October 8, 1996 Advertising Do Published, Original Data Funded Dissemination of Reference October 8, 1996 Do Do Texts Antifungal (topical) February 24, 1990 Biopharmaceutic Drug Information Branch (Draft) Antifungal (vaginal) February 24, 1990 Do Do Food-Effect Bioavailability and December 30, 1997...
FDA Drug Approvals List November 1999 Approvable Original New Drug Applications Original Application #: 020125 Approvable Date: 30-NOV-99 Trade Name: ACCURETIC Dosage Form: TABLET Applicant: PARKE DAVIS PHARMACEUTICAL RESEARCH DIV WARNER LAMBERT CO Active Ingredient(s): QUINAPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE OTC/RX Status: RX Original Abbreviated Application #: 075366 Tentative Approval Date: 02-NOV-99 Trade Name:...
http://www.fda.gov/cder/foi/appletter/1999/40359ltr.pdf page 1
Drug Approvals November 1996 Application #: 050580; Efficacy Supplement #: 008 Type: SE1 to Original New Drug Application Approval Date: 01-NOV-96 Trade Name: AZACTAM Dosage Form: INJECTABLE Applicant: ER SQUIBB AND SONS INC Active Ingredient(s): AZTREONAM OTC/RX Status: RX Efficacy Claim: Expanded use of Azactam in pediatric patients Application #: 019918; Efficacy Supplement #: 004 Type: SE1 to Original New...
http://www.fda.gov/cder/da/ddpa91.wpd 19 531 NUTRILI 10% MCGAW SOYBEAN OIL 02 08 91 (INJECTABLE) IRVINE, CA 10% 92713 (NUTRIENT REPLENISHER) 19 531 NUTRILI 20% MCGAW SOYBEAN OIL 02 08 91 (INJECTABLE) IRVINE, CA 20% 92713 (NUTRIENT REPLENISHER) 20-069 DIANEAL PD-2 BAXTER CALCIUM CHLORIDE 02-19-91 ELECTROLYTE ROUND LAKE, IL 514MG/100ML CONCENTRATE 60073 MAGNESIUM CHLORIDE IN PLASTIC CONTAINER 102MG/100ML (SOLUTION) SODIUM...
